Akebia Therapeutics Inc (AKBA)
1.845
+0.16
(+9.17%)
USD |
NASDAQ |
Nov 04, 16:00
1.85
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 30, 2023 | 19.84 |
March 29, 2023 | 21.31 |
March 28, 2023 | 21.11 |
March 27, 2023 | 23.12 |
March 24, 2023 | 22.50 |
March 23, 2023 | 24.15 |
March 22, 2023 | 23.52 |
March 21, 2023 | 24.66 |
March 20, 2023 | 23.85 |
March 17, 2023 | 22.36 |
March 16, 2023 | 25.10 |
March 15, 2023 | 23.66 |
March 14, 2023 | 24.07 |
March 13, 2023 | 26.61 |
March 10, 2023 | 28.15 |
March 09, 2023 | 28.21 |
March 08, 2023 | 36.29 |
March 07, 2023 | 33.31 |
March 06, 2023 | 33.19 |
March 03, 2023 | 34.00 |
March 02, 2023 | 32.69 |
March 01, 2023 | 32.23 |
February 28, 2023 | 29.69 |
February 27, 2023 | 28.73 |
February 24, 2023 | 29.07 |
Date | Value |
---|---|
February 23, 2023 | 26.07 |
February 22, 2023 | 24.38 |
February 21, 2023 | 23.04 |
February 17, 2023 | 30.93 |
February 16, 2023 | 30.40 |
February 15, 2023 | 31.22 |
February 14, 2023 | 29.94 |
February 13, 2023 | 27.94 |
February 10, 2023 | 28.27 |
February 09, 2023 | 39.46 |
February 08, 2023 | 40.51 |
February 07, 2023 | 39.81 |
February 06, 2023 | 37.69 |
February 03, 2023 | 34.74 |
February 02, 2023 | 31.35 |
February 01, 2023 | 23.60 |
January 31, 2023 | 22.19 |
January 30, 2023 | 21.27 |
January 27, 2023 | 23.59 |
January 26, 2023 | 25.00 |
January 25, 2023 | 25.07 |
January 24, 2023 | 25.43 |
January 23, 2023 | 25.01 |
January 20, 2023 | 25.94 |
January 19, 2023 | 24.97 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8039
Minimum
Nov 18 2019
40.51
Maximum
Feb 08 2023
4.588
Average
2.774
Median
Feb 10 2020
Price to Book Value Benchmarks
Corcept Therapeutics Inc | 8.212 |
Bioventus Inc | 5.911 |
Eli Lilly and Co | 53.74 |
NovaBay Pharmaceuticals Inc | -- |
Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 2.096 |
Price | 1.845 |
Earnings Yield | -11.21% |
Market Cap | 387.98M |